Stockreport

Moderna shares fall as FDA declines to review new flu vaccine [BNN Bloomberg (Canada)]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The decision deals a blow to Moderna's ambitions to plug the decline in its COVID-19 vaccine revenue and demonstrate the long-term viability of its mRNA platform. Swe [Read more]